A carregar...
Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin
Triple-negative breast cancer (TNBC) is an aggressive form of breast cancer for which there is no effective treatment. Previously, we and others demonstrated that CXCR4 surface expression is an independent prognostic factor for disease relapse and survival in breast cancer. In this study, we investi...
Na minha lista:
| Publicado no: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals LLC
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4359214/ https://ncbi.nlm.nih.gov/pubmed/25544759 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|